Osteoporosis Clinical Trial
The genetic bases of peak bone mass in males, as determinants of an individual’s risk of
developing osteoporotic fractures in old age and their interaction with dietary and
lifestyle factors are still poorly understood.
Our objective was to examine the relative contribution of genetic and environmental
variables to the regulation of peak bone mass in a population-based cohort of young healthy
men, focusing on the BsmI polymorphism of vitamin D receptor (VDR)gene and the AluI
polymorphism of calcitonin receptor (CTR)gene.
Material and Methods
Subjects
In this cross-sectional study, 301 Greek healthy young men, aged 16-35 were selected during
gradational examinations for the Greek Armed forces. Men who were treated with
corticosteroids, anticonvulsants, or anticoagulants or who suffered from hypogonadism,
kidney, liver, thyroid and gastrointestinal disease or diabetes mellitus were excluded from
the study.
Approval by the hospital ethics committee and informed consent were obtained. Height and
body weight were measured with the subjects in sportswear, standing barefoot on a fixed
stadiometer and on a standard clinical balance. Height was recorded in centimetres and
weight in kilograms. The stadiometer and scale were routinely monitored for accuracy and
precision. Body mass index (BMI) was calculated as weight/height 2 .
Dietary Evaluation
Current dietary factors (calcium, proteins, alcohol, coffee and tea intake), were assessed
using a food frequency questionnaire validated in the MEDOS study, and completed with an
interview. Calcium intake was estimated considering milk, yogurt and cheese consumption.
Protein intake was estimated by taking into account the consumption of meat and fish per
week. Tea and coffee consumption was also taken into account.
Nondieter factors were investigated using a questionnaire
Physical was quantified as hours of sports activities per week (defined as taking part in
organized sport for at least 12 months). Smoking behaviour was coded as ‘yes’ (daily
smoking) or ‘no’, and sunlight exposure when there was exposure in places abroad during the
previous 3 months. Duration of immobilizations was also coded as ‘less’ or ‘more than 1
month’ (in majority, due to fractures caused by high energy trauma).
Genetic analyses
Genomic DNA was extracted from peripheral blood leukocytes with a DNA extraction kit
(Puregene DNA isolation kit, Gentra Systems Inc., Munich, Germany). Polymorphisms in the CTR
and VDR genes were determined by polymerase chain reaction (PCR) as previously described
using Taq DNA polymerase (Takara, Tokyo, Japan), and thermal cycler (PCR Primus 96 plus-MWG
AG BIOTECH). 4μl of CTR-PCR product were digested with AluI (New England Biolabs, UK) and 2
μl of VDR-PCR product were digested with BsmI (New England Biolabs, UK) according to
manufacturer’s instructions. AluI restriction digest yielded DNA fragments of 120/108-bp
(TT), 228/120/108-bp (TC) and 228-bp (CC) and BsmI restriction digest yielded DNA fragments
of 1200/650-bp (bb), 1850/1200/650-bp (Bb) and 1850-bp (BB), which were visualized using a
3% and 1% agarose gel respectively stained with ethidium bromide.
BMD Measurements
Distal BMC (dBMC), distal BMD (dBMD) and ultradistal BMD (udBMD) at the radius were measured
by single X-ray absorptiometry (Osteometer DTX-100, Denmark). Additionally, there were
assessments of the corresponding geometrical areas, such as radial area (RadAr), ulnar area
(UlnAr) and ultradistal area (udAr). BMD is expressed as grams/cm2; BMC is expressed in
grams and Area as cm2 The in vivo precision for the BMD and BMC measurements in our
laboratory was 1-5%.
Statistical Analysis
Descriptive statistics were determined for all variables. All variables are sufficiently
represented using the mean value (mean) and standard deviation (SD).
Univariate analysis was performed using the two-sample Student’s test or Welch-test (in a
case of unequal SDs) and the model of one-way analysis of variance with no repeated
measurements (pairwise multiple comparisons were analysed using the Tukey test). Analysis of
covariance (ANCOVA) used the bone values (BMC, BMD, Area) as dependent variables, the VDR
and CTR polymorphisms as factors and age, weight and height as covariates. Furthermore,
multiple stepwise regression analysis was used to determine significant predictors of BMD.
All tests are two sided; P<0, 05 was defined as significant. All data analysis was performed
using the Statistical Package for Social Sciences (version 10.0) software (SPSS Inc.,
Chicago, IL).
;
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
| Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
| Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
| Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
| Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
| Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
| Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
| Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
| Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
| Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
| Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
| Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
| Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
| Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
| Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
| Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
| Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
| Completed |
NCT02143674 -
Muscle Strengthening Exercises and Global Stretching in Elderly
|
N/A |